Abstract
A 38-year-old Japanese woman with severe aplastic anemia received an allogeneic bone marrow transplant from her serologically HLA-identical father. Cyclosporine and methotrexate were administered to prevent graft-versus-host disease (GVHD). However, grade III acute GVHD developed on day 44, which was successfully treated with methylprednisolone and tacrolimus. Fluconazole therapy was started for oral candidiasis on day 112, but she complained of headache soon after. In addition to glycosuria and increased serum creatinine levels, Pelger–Huët anomaly of granulocytes was found in her blood, which disappeared after discontinuation of tacrolimus. Transient occurrence of Pelger–Huët cells may be associated with tacrolimus toxicity due to drug interaction with fluconazole. Bone Marrow Transplantation (2000) 26, 1255–1257.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kouides PA, Bennett J . Morphology and classification of the myelodysplastic syndromes and their pathologic variants Semin Hematol 1996 33: 95–110
Kaplan JM, Barrett O . Reversible pseudo-Pelger anomaly related to sulfisoxazole therapy New Engl J Med 1967 277: 421–422
Juneja SK, Matthews JP, Luzinat R et al. Association of acquired Pelger–Hüet anomaly with taxoid therapy Br J Haematol 1996 93: 139–141
Orchard JA, Bolam S, Oscier DG . Association of myelodysplastic changes with purine analogues Br J Haematol 1998 100: 677–679
Gondo H, Harada M, Taniguchi S et al. Cyclosporine combined with methylprednisolone or methotrexate in prophylaxis of moderate to severe acute graft-versus-host disease Bone Marrow Transplant 1993 12: 437–441
Letko E, Bhol K, Pinar V et al. Tacrolimus (FK506) Ann Allergy Asthma Immunol 1999 83: 179–190
Mañez R, Martin M, Raman V et al. Fluconazole therapy in transplant recipients receiving FK506 Transplantation 1994 57: 1521–1535
Backman L, Nicar M, Levy M et al. FK506 trough levels in whole blood and plasma in liver transplant recipients Transplantation 1994 57: 519–525
Alessiani M, Cillo U, Fung JJ et al. Adverse effects of FK506 overdosage after liver transplantation Transplant Proc 1993 25: 628–634
Krentz AJ, Dmitrewski J, Mayer D et al. Postoperative glucose metabolism in liver transplant recipients: a two-year prospective randomized study of cyclosporine versus FK506 Transplantation 1994 57: 1666–1669
Bhatia S, Ramsay NKC, Steinbuch M et al. Malignant neoplasms following bone marrow transplantation Blood 1996 87: 3633–3639
Socie G, Henry-Amar M, Bacigalupo A et al. Malignant tumors occurring after treatment of aplastic anemia New Engl J Med 1993 329: 1152–1157
Acknowledgements
This work was supported in part by the Grant-in-Aid for Cancer Research (7–3) from the Ministry of Health and Welfare.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gondo, H., Okamura, C., Osaki, K. et al. Acquired Pelger–Huët anomaly in association with concomitant tacrolimus and fluconazole therapy following allogeneic bone marrow transplantation. Bone Marrow Transplant 26, 1255–1257 (2000). https://doi.org/10.1038/sj.bmt.1702682
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702682
Keywords
This article is cited by
-
Occurrence of neutrophil dysplasia in the course of severe nephrotic syndrome in a 12-year-old boy on immunosuppressive therapy: Answers
Pediatric Nephrology (2017)
-
Hematologic abnormalities following renal transplantation
International Urology and Nephrology (2010)